Osteoporosis Treatment Market: By Products (Drugs (Antibodies, Bisphosphonates), Hormones (Parathyroid Hormone, Thyrocalcitonin, Selective Estrogen Receptor Modulators)), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Osteoporosis Treatment Market was valued at USD 13,603.8 million in 2022 and is anticipated to grow at a CAGR of 4.2% over 2023-2029. The osteoporosis treatment market refers to the pharmacological and therapeutic interventions aiming for the management and treatment of osteoporosis. Osteoporosis is a medical disorder that develops when bone mineral density and bone mass decline, or when bone quality or structure changes, which can result in a loss in bone strength, increasing the risk of fractures. Osteoporosis treatment's primary purpose is to reduce bone loss, strengthen bones, and prevent fractures. Medication, lifestyle changes, and dietary supplements are among the therapeutic options available. Medications commonly prescribed for osteoporosis include bisphosphonates, selective estrogen receptor modulators (SERMs), hormone replacement therapy (HRT), and monoclonal antibodies which promise to improve overall bone health.  The osteoporosis treatment market has witnessed significant growth due to the rising prevalence of osteoporosis worldwide, particularly among the aging population.

According to research study, more than 200 million people are estimated to have osteoporosis, and based on the latest data from the International Osteoporosis Foundation; one in every three women over the age of 50 and one in every five men will suffer from fractures associated with osteoporosis in their lifetime. As a result, there is a growing demand for effective osteoporosis treatments, which accelerates the growth of the osteoporosis treatment market. The expanding geriatric population along with the advancements in novel treatment options presents a significant opportunity for the osteoporosis treatment market. Apart from this, some of the recent trends such as rising adoption of biologic therapies and integration of digital health technologies are shaping the growth of the osteoporosis treatment market. However, some osteoporosis treatments, such as bisphosphonates, may be associated with side effects, including nausea, abdominal pain, and heartburn-like symptoms which pose challenges for the growth of the osteoporosis treatment market. Major pharmaceutical companies are continuously involved in research and development and launching new treatment options which further expands the osteoporosis treatment market.

Osteoporosis Treatment Market Key Developments:  
  • In December 2022, Chugai Pharmaceutical Co., Ltd. and Towa Pharmaceutical Co., Ltd. launched Edirol Tablets 0.5 µg/0.75 µg (generic name: eldecalcitol, hereafter, Edirol Tablet) for osteoporosis treatment.
  • In January 2023, Teijin Pharma Limited announced to launch Japan-market sales of abaloparatide acetate for osteoporosis under the tradename OSTABALO.

Osteoporosis Treatment Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

4.2%

Largest Market

North America

Fastest Growing Market

North America
Osteoporosis Treatment Market Dynamics

Global osteoporosis treatment market primarily driven by rise in prevalence of the osteoporosis and obese patients around the world. According to International Osteoporosis Foundation, about 200 million people were diagnosed with the osteoporosis around the world. In addition, rise in research and development investments in development of drugs, innovative pipeline therapies such as monoclonal antibodies expected to boost the market growth over the forecast period. Furthermore, rise in prevalence of the disease in post-menopausal woman, rise in awareness about the disease symptoms, ageing population expected to bolster the market share. However, the side effects of the osteoporosis drugs, high cost of drug discovery and development projected to hamper the market growth over the forecast period.

Key Features of the Reports

  • The osteoporosis treatment market report provides granular level information about the market size, regional market share, historic market (2018-2022), and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Osteoporosis Treatment Market Segmentation

By Therapy Type
  • Drug therapy
    • Antibodies
    • Bisphosphonates
  • Hormonal Therapy
    • Parathyroid Hormone
    • Thyrocalcitonin
    • Selective Estrogen Receptor Modulators
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
By Geography
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • Middle East and Africa (MEA)

Frequently Asked Questions

The osteoporosis treatment market was valued at USD 13,603.8 million in 2022

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Novartis AG (Switzerland), Pfizer Inc. (U.S.), Hoffmann-La Roche AG (Switzerland), Eli Lilly and Company (U.S.), Teva Pharmaceutical Industries (Denmark)

1.Executive Summary
2.Global Osteoporosis Treatment Market Introduction 
2.1.Global Osteoporosis Treatment Market  - Taxonomy
2.2.Global Osteoporosis Treatment Market  - Definitions
2.2.1. By Therapy Type
2.2.2. By Distribution Channel
2.2.3. By Region
3.Global Osteoporosis Treatment Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Osteoporosis Treatment Market Analysis, 2018 - 2022 and Forecast 2023 - 2029
4.1.  Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Osteoporosis Treatment Market  By Therapy Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
5.1. Drug therapy
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Hormonal Therapy
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
6.Global Osteoporosis Treatment Market  By Distribution Channel, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
6.1. Hospital Pharmacies
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Retail Pharmacies
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Online Pharmacies
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Osteoporosis Treatment Market  By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
7.1. North America
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Europe
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Asia Pacific (APAC)
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Middle East and Africa (MEA)
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
7.5. Latin America
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million)
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.5.3. Market Opportunity Analysis 
8.North America Osteoporosis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
8.1. Therapy Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.1.1.Drug therapy
8.1.2.Hormonal Therapy
8.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.2.1.Hospital Pharmacies
8.2.2.Retail Pharmacies
8.2.3.Online Pharmacies
8.2.4.Others
8.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
8.3.1.United States of America (USA)
8.3.2.Canada
9.Europe Osteoporosis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
9.1. Therapy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Drug therapy
9.1.2.Hormonal Therapy
9.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Hospital Pharmacies
9.2.2.Retail Pharmacies
9.2.3.Online Pharmacies
9.2.4.Others
9.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Germany
9.3.2.France
9.3.3.Italy
9.3.4.United Kingdom (UK)
9.3.5.Spain
10.Asia Pacific (APAC) Osteoporosis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
10.1. Therapy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Drug therapy
10.1.2.Hormonal Therapy
10.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Hospital Pharmacies
10.2.2.Retail Pharmacies
10.2.3.Online Pharmacies
10.2.4.Others
10.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.China
10.3.2.India
10.3.3.Australia and New Zealand (ANZ)
10.3.4.Japan
10.3.5.Rest of APAC
11.Middle East and Africa (MEA) Osteoporosis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
11.1. Therapy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Drug therapy
11.1.2.Hormonal Therapy
11.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Hospital Pharmacies
11.2.2.Retail Pharmacies
11.2.3.Online Pharmacies
11.2.4.Others
11.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.GCC Countries
11.3.2.South Africa
11.3.3.Rest of MEA
12.Latin America Osteoporosis Treatment Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million)
12.1. Therapy Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Drug therapy
12.1.2.Hormonal Therapy
12.2.  Distribution Channel Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Hospital Pharmacies
12.2.2.Retail Pharmacies
12.2.3.Online Pharmacies
12.2.4.Others
12.3.  Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Brazil
12.3.2.Mexico
12.3.3.Rest of LA
13. Competition Landscape
13.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
13.2.1.Novartis AG (Switzerland)
13.2.2.Pfizer Inc. (U.S.)
13.2.3.Hoffmann-La Roche AG (Switzerland)
13.2.4.Eli Lilly and Company (U.S.)
13.2.5.Teva Pharmaceutical Industries (Denmark)
13.2.6.Novo Nordisk (Denmark)
13.2.7.Cipla (India)
13.2.8.Allergan plc (Ireland)
13.2.9.Radius Health (U.S.)
14. Research Methodology 
15. Appendix and Abbreviations 
  • Novartis AG (Switzerland)
  • Pfizer Inc. (U.S.)
  • Hoffmann-La Roche AG (Switzerland)
  • Eli Lilly and Company (U.S.)
  • Teva Pharmaceutical Industries (Denmark)
  • Novo Nordisk (Denmark)
  • Cipla (India)
  • Allergan plc (Ireland)
  • Radius Health (U.S.)

Adjacent Markets